Article info
PDFShort report
Sampling endoscopically normal large bowel mucosa from patients presenting with elevated faecal calprotectin levels is not clinically justified
- Correspondence to Dr Newton A C S Wong, Cellular Pathology, Southmead Hospital, Bristol BS10 5NB, UK; Nacs.Wong{at}bristol.ac.uk
Citation
Sampling endoscopically normal large bowel mucosa from patients presenting with elevated faecal calprotectin levels is not clinically justified
Publication history
- Received December 15, 2020
- Revised January 14, 2021
- Accepted January 16, 2021
- First published January 28, 2021.
Online issue publication
February 17, 2022
Article Versions
- Previous version (17 February 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.